Social DistanceNCT04555122
COVID-19 Ad Intervention
A study testing Social Distancing Advertisements in people with Social Distance, run by University of California, Irvine at 1 site in United States.
Trial summary
This study will provide advertisements to (de-identified) participants and track (de-identified) movement patterns to learn whether the ads increase adherence to stay-at-home orders. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Social Distance
- What is being tested?
- Social Distancing Advertisements
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Oct 2021to 28 Jul 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 18 years of age or older (as identified by company running advertisements); recent visit to a non-essential location; agreed to terms and conditions of websites allowing advertisements
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
Official title: COVID-19 Ad Intervention for Social Distancing
This study will provide advertisements to (de-identified) participants and track (de-identified) movement patterns to learn whether the ads increase adherence to stay-at-home orders.
- Conditions
- Social Distance
- Being tested
- Social Distancing Advertisements
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Social Distancing AdvertisementsBehavioural
Participants will receive 3 types of advertisements to increase social distancing/staying at home.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | Advertisements will be sent to participants to attempt to increase adherence to stay-at-home orders and social distancing. There are 3 types of advertisements. This will occur for 7 days. Receives: Behavioral: Social Distancing Advertisements |
| Control Group | No intervention | Control Group will be people who will not receive any advertisements. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mobility
Amount of time that participants are outside of their primary location/home
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2020
- Study start1 Oct 2021 (estimated)
- Primary completion28 May 2022 (estimated)
- Study completion28 Jul 2022 (estimated)
Why it stopped: Per Sponsor Request; nonACT
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Social DistanceStudies of the same condition, open and under way.
- More trials run by University of California, IrvineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of California, Irvine
- Sponsor type
- University, hospital or other
- Collaborators
- City University of Hong Kong, University of California, Los Angeles
- Responsible party
- Principal investigator, Sean D Young, University of California, Irvine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04555122
- Sponsor's protocol ID
- IRB# 20205923
- Status last verified
- May 2023
- First submitted
- 29 Apr 2020
- Last updated
- 3 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- COVID-19 Ad Intervention for Social Distancing
- ClinicalTrials.gov ID
- NCT04555122
- Acronym / sponsor ID
- IRB# 20205923
- Conditions
- Social Distance
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Per Sponsor Request; nonACT
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University of California, IrvineUniversity, hospital or other
- Collaborators
- City University of Hong Kong, University of California, Los Angeles
- Study start
- 1 Oct 2021 (estimated)
- Primary completion
- 28 May 2022 (estimated)
- Study completion
- 28 Jul 2022 (estimated)
- First posted
- 18 Sep 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will provide advertisements to (de-identified) participants and track (de-identified) movement patterns to learn whether the ads increase adherence to stay-at-home orders.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Experimental | Behavioral: Social Distancing AdvertisementsAdvertisements will be sent to participants to attempt to increase adherence to stay-at-home orders and social distancing. There are 3 types of advertisements. This will occur for 7 days. |
| Control Group | No intervention | –Control Group will be people who will not receive any advertisements. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- 18 years of age or older (as identified by company running advertisements); recent visit to a non-essential location; agreed to terms and conditions of websites allowing advertisements
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Social Distancing AdvertisementsParticipants will receive 3 types of advertisements to increase social distancing/staying at home. | Behavioural | Intervention Group |
Primary outcome
Mobility
Time frame: 7 days
Amount of time that participants are outside of their primary location/home
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2023.
- Individual participant dataSharing planned: No
Related trials for Social Distance
Active, not recruiting
An At-distance and Online Intervention to Promote Parental Involvement and Self-regulation
Parental Involvement, Self-regulation in Children
Active, not recruiting
Diet, Food, Exercise and Nutrition During Social Distancing
Healthy Lifestyle, Sleep
Not yet recruitingObservational study
Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders
Duchenne / Becker Muscular Dystrophy, Osteogenesis Imperfecta (OI)
Active, not recruitingObservational study
First Level Socio-geriatric Evaluation: ESOGER Databank
COVID, Social Isolation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Social Distancing Advertisements in people with Social Distance, run by University of California, Irvine at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 3 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mobility (time frame: 7 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2023.